Epigenetic determinants of healthy and diseased brain aging and cognition.

A better understanding of normal and diseased brain aging and cognition will have a significant public health impact, given that the oldest-old persons older than 85 years of age represent the fastest-growing segment in the population in developed countries, with more than 30 million new cases of dementia predicted to occur worldwide each year by 2040. Dysregulation of gene expression and, more generally, genome organization and function are thought to contribute to age-related declines in cognition. Remarkably, nearly all neuronal nuclei that reside in an aged brain had permanently exited from the cell cycle during prenatal development, and DNA methylation and histone modifications and other molecular constituents of the epigenome are likely to play a critical role in the maintenance of neuronal health and function throughout the entire lifespan. Here, we provide an overview of age-related changes in the brain's chromatin structures, highlight potential epigenetic drug targets for cognitive decline and age-related neurodegenerative disease, and discuss opportunities and challenges when studying epigenetic biomarkers in aging research.

[1]  K. Zhang,et al.  DNA Demethylation Dynamics in the Human Prenatal Germline , 2015, Cell.

[2]  J. Karlseder,et al.  The great unravelling: chromatin as a modulator of the aging process. , 2012, Trends in biochemical sciences.

[3]  Kenny Q. Ye,et al.  Distinguishing between longevity and buffered-deleterious genotypes for exceptional human longevity: the case of the MTP gene. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  S. Horvath,et al.  Aging effects on DNA methylation modules in human brain and blood tissue , 2012, Genome Biology.

[5]  V. Haroutunian,et al.  C-reactive protein and familial risk for dementia , 2012, Neurology.

[6]  B. Blencowe,et al.  5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary , 2012, Nature Structural &Molecular Biology.

[7]  Lee E. Edsall,et al.  A map of the cis-regulatory sequences in the mouse genome , 2012, Nature.

[8]  L. Partridge,et al.  The place of genetics in ageing research , 2012, Nature Reviews Genetics.

[9]  D. Berlau,et al.  A population-based clinicopathological study in the oldest-old: the 90+ study. , 2012, Current Alzheimer research.

[10]  S. Noctor,et al.  CoREST/LSD1 control the development of pyramidal cortical neurons. , 2012, Cerebral cortex.

[11]  G. Ronnett,et al.  AMP-Activated Protein Kinase (AMPK) and Energy-Sensing in the Brain , 2012, Experimental neurobiology.

[12]  Fabian Grubert,et al.  Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. , 2012, Human molecular genetics.

[13]  D. Bennett,et al.  Dementia from Alzheimer disease and mixed pathologies in the oldest old. , 2012, JAMA.

[14]  Darnell,et al.  Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease , 2012, Neurobiology of Disease.

[15]  S. Kügler,et al.  HDAC1 Regulates Fear Extinction in Mice , 2012, The Journal of Neuroscience.

[16]  H. Vinters,et al.  Targeted proteomics for quantification of histone acetylation in Alzheimer's disease , 2012, Proteomics.

[17]  J. Kleinman,et al.  DNA methylation signatures in development and aging of the human prefrontal cortex. , 2012, American journal of human genetics.

[18]  P. Matthias,et al.  Multiple roles of class I HDACs in proliferation, differentiation, and development , 2012, Cellular and Molecular Life Sciences.

[19]  J. Bader,et al.  Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK , 2011, Nature.

[20]  S Purcell,et al.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.

[21]  J. Schmeidler,et al.  Haemoglobin A(1c) and cognitive function in very old, cognitively intact men. , 2012, Age and ageing.

[22]  Howard Hu,et al.  Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. , 2012, Journal of Alzheimer's disease : JAD.

[23]  G. Brewer,et al.  Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer’s disease , 2012, AGE.

[24]  B. Dean,et al.  Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders , 2011, Translational Psychiatry.

[25]  Warren J Manning,et al.  Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study). , 2011, The American journal of cardiology.

[26]  T. Kleefstra,et al.  Kleefstra syndrome in three adult patients: Further delineation of the behavioral and neurological phenotype shows aspects of a neurodegenerative course , 2011, American journal of medical genetics. Part A.

[27]  M. Dragunow,et al.  Epigenetics in Alzheimer's disease: a focus on DNA modifications. , 2011, Current pharmaceutical design.

[28]  Zhike Lu,et al.  Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification , 2011, Cell.

[29]  H. Blau,et al.  DNA Demethylation Dynamics , 2011, Cell.

[30]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[31]  I. Skoog.  Psychiatric Disorders in the Elderly , 2011, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[32]  C. Lyketsos,et al.  Epidemiology, assessment, and treatment of dementia. , 2011, The Psychiatric clinics of North America.

[33]  G. Ming,et al.  Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain , 2011, Cell.

[34]  Elizabeth J. Atkinson,et al.  Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss , 2011, Nature Genetics.

[35]  K. Jellinger,et al.  Clinicopathological correlates of behavioral and psychological symptoms of dementia , 2011, Acta Neuropathologica.

[36]  E. Masliah,et al.  Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. , 2011, The Journal of biological chemistry.

[37]  S. Murphy,et al.  Histone Deacetylase Inhibitors Preserve White Matter Structure and Function during Ischemia by Conserving ATP and Reducing Excitotoxicity , 2011, The Journal of Neuroscience.

[38]  Mark R Cookson,et al.  Distinct DNA methylation changes highly correlated with chronological age in the human brain. , 2011, Human molecular genetics.

[39]  Solve Sæbø,et al.  A gene expression pattern in blood for the early detection of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[40]  B. Bernstein,et al.  Charting histone modifications and the functional organization of mammalian genomes , 2011, Nature Reviews Genetics.

[41]  L. Tsai,et al.  Targeting the correct HDAC(s) to treat cognitive disorders. , 2010, Trends in pharmacological sciences.

[42]  L. Monteggia,et al.  Histone deacetylases govern cellular mechanisms underlying behavioral and synaptic plasticity in the developing and adult brain , 2010, Behavioural pharmacology.

[43]  F. A. Schroeder,et al.  Setdb1 Histone Methyltransferase Regulates Mood-Related Behaviors and Expression of the NMDA Receptor Subunit NR2B , 2010, The Journal of Neuroscience.

[44]  Lennart Opitz,et al.  Altered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice , 2010, Science.

[45]  D. Molfese,et al.  Histone Methylation Regulates Memory Formation , 2010, The Journal of Neuroscience.

[46]  Paul Greengard,et al.  Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity , 2010, Science.

[47]  G. Crabtree,et al.  Chromatin remodelling during development , 2010, Nature.

[48]  Y. Kwan,et al.  Identification of histone methylation multiplicities patterns in the brain of senescence-accelerated prone mouse 8 , 2010, Biogerontology.

[49]  P. Casaccia‐Bonnefil,et al.  Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging , 2009, Glia.

[50]  Yan Leng,et al.  Multiple roles of HDAC inhibition in neurodegenerative conditions , 2009, Trends in Neurosciences.

[51]  Vahram Haroutunian,et al.  Gain in Brain Immunity in the Oldest-Old Differentiates Cognitively Normal from Demented Individuals , 2009, PloS one.

[52]  J. Vaupel,et al.  Ageing populations: the challenges ahead , 2009, The Lancet.

[53]  V. Haroutunian,et al.  Better cognitive performance associated with worse cardiac functioning suggests antagonistic pleiotropy in very elderly subjects. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[54]  Emma Y. Wu,et al.  Antidepressant Actions of Histone Deacetylase Inhibitors , 2009, The Journal of Neuroscience.

[55]  Robert A. Copeland,et al.  Protein methyltransferases as a target class for drug discovery , 2009, Nature Reviews Drug Discovery.

[56]  R. Medzhitov,et al.  Control of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation , 2009, Cell.

[57]  J. Sutcliffe,et al.  Normal human aging and early‐stage schizophrenia share common molecular profiles , 2009, Aging cell.

[58]  R. Pfundt,et al.  Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype , 2009, Journal of Medical Genetics.

[59]  S. Akbarian,et al.  Epigenetic Regulation in Human Brain—Focus on Histone Lysine Methylation , 2009, Biological Psychiatry.

[60]  A. Guidotti,et al.  Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. , 2009, Trends in pharmacological sciences.

[61]  G. Elder,et al.  C-reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects. , 2008, Age and ageing.

[62]  Robert B. Wilson,et al.  Pharmacotherapy for Friedreich Ataxia , 2009, CNS drugs.

[63]  Sonja Zehetmayer,et al.  Gene expression as peripheral biomarkers for sporadic Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[64]  R Brookmeyer,et al.  Prevalence of dementia after age 90 , 2008, Neurology.

[65]  Sun-Chong Wang,et al.  Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease , 2008, PloS one.

[66]  Tao Lu,et al.  The aging brain. , 2008, Annual review of pathology.

[67]  A. Börjesson-Hanson,et al.  Five-year mortality in relation to dementia and cognitive function in 95-year-olds , 2007, Neurology.

[68]  Guanghua Xiao,et al.  Histone Deacetylase 5 Epigenetically Controls Behavioral Adaptations to Chronic Emotional Stimuli , 2007, Neuron.

[69]  Sean D. Taverna,et al.  How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers , 2007, Nature Structural &Molecular Biology.

[70]  Stephen P. Baker,et al.  Prefrontal Dysfunction in Schizophrenia Involves Mixed-Lineage Leukemia 1-Regulated Histone Methylation at GABAergic Gene Promoters , 2007, The Journal of Neuroscience.

[71]  R. Jaenisch,et al.  DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons , 2007, PloS one.

[72]  F. A. Schroeder,et al.  Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse , 2007, Biological Psychiatry.

[73]  P. Ridker.  C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. , 2007, Journal of the American College of Cardiology.

[74]  S. Korsmeyer,et al.  Developmental Regulation of Eed Complex Composition Governs a Switch in Global Histone Modification in Brain* , 2007, Journal of Biological Chemistry.

[75]  S. Horinouchi,et al.  Multiple Histone Deacetylases and the CREB-binding Protein Regulate Pre-mRNA 3′-End Processing* , 2007, Journal of Biological Chemistry.

[76]  Karl Mechtler,et al.  Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. , 2007, Molecular cell.

[77]  A. Belmont.  Mitotic chromosome structure and condensation. , 2006, Current opinion in cell biology.

[78]  Kaare Christensen,et al.  The quest for genetic determinants of human longevity: challenges and insights , 2006, Nature Reviews Genetics.

[79]  E. Nestler,et al.  Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action , 2006, Nature Neuroscience.

[80]  Robin Holliday,et al.  Epigenetics: A Historical Overview , 2006, Epigenetics.

[81]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[82]       .  Global prevalence of dementia: a Delphi consensus study , 2006 .

[83]  D. Mann,et al.  Is there a relation between APOE expression and brain amyloid load in Alzheimer’s disease? , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[84]  M. Malaguarnera,et al.  Successful aging in centenarians: myths and reality. , 2005, Archives of gerontology and geriatrics.

[85]  H. Loh,et al.  Retinoic Acid-Induced Chromatin Remodeling of Mouse κ Opioid Receptor Gene , 2005, The Journal of Neuroscience.

[86]  H. Loh,et al.  Retinoic acid-induced chromatin remodeling of mouse kappa opioid receptor gene. , 2005, Journal of Neuroscience.

[87]  J. Schmeidler,et al.  Diabetes mellitus in midlife and the risk of dementia three decades later , 2004, Neurology.

[88]  B. Gurland,et al.  A twin study of the genetic contribution to age-related functional impairment. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[89]  I. Kohane,et al.  Gene regulation and DNA damage in the ageing human brain , 2004, Nature.

[90]  M. Caldwell,et al.  American Heart Association: Council on Cardiovascular Nursing , 2004, The Journal of cardiovascular nursing.

[91]  R. Schmidt,et al.  Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study , 2002, Annals of neurology.

[92]  P. Zandi,et al.  Incidence of AD may decline in the early 90s for men, later for women , 2002, Neurology.

[93]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[94]  C. Wijmenga,et al.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[95]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.